Labeled [3H] - Thymidine incorporation in the DNA of 3T3-L1 preadipocytes due to MT2- and not MT3- melatonin receptor

Journal of Physiology and Pharmacology

Volumn 65, Issue 1, 2014, Pages 135-143

  Adamczyk Sowa, Monika ^a   Sowa, P ^a   Zwirska Korczala, K ^a   Pierzchala, K ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

3T3 L1 proliferation; Luzindole; Melatonin; Melatonin receptors; Obesity; Prazosin; Preadipocytes

Indexed keywords

LUZINDOLE; MELATONIN RECEPTOR; PRAZOSIN;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; CYTOLOGY; DNA SYNTHESIS; INCUBATION TIME; MOUSE; NONHUMAN; OBESITY; PROADIPOCYTE; QUANTITATIVE ASSAY;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL PROLIFERATION; DNA; MELATONIN; MICE; PRAZOSIN; RECEPTOR, MELATONIN, MT2; RECEPTORS, MELATONIN; THYMIDINE; TRYPTAMINES;

EID: 84896805937     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
2. Schaffler A, Muller-Ladner U, Scholmerich J, Buchler C. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 2006; 27: 449-467.
3. Green H, Kehinde O. An established preadipose cell line and its differentiation in culture. Factors affecting the adipose conversion. Cell 1975; 5: 19-27.
4. DiGirolamo M, Fine JB, Tagra K, Rossmanith R. Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum. Am J Physiol 1998; 274: R1460-R1467.
5. Jones DD, Ramsay TG, Hausman GJ, Martin RJ. Norepinephrine inhibits rat preadipocyte proliferation. Int J Obes Relat Metab Disord 1992; 16: 349-354.
6. Valet P, Pages C, Jeanneton O, et al. Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin Invest 1998; 101: 1431-1438.
7. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. The biology of white adipocyte proliferation. Obes Rev 2001; 2: 239-254.
8. Monjo M, Pujol E, Roca P. Alpha2-to beta3-adrenoceptor switch in 3T3 L1 preadipocytes and adipocytes: modulation by testosterone, 17beta-estradiol, and progesterone. Am J Physiol Endocrinol Metab 2005; 289: E145-E150.
9. Alvarez-Garcia V, Gonzalez A, Alonso-Gonzalez C, Martinez-Campa C, Cos S. Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production. J Pineal Res 2012; 52: 282-290.
10. Brydon L, Petit L, Delagrange P, Strosberg AD, Jockers R. Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology 2001; 142: 4264-4271.
11. Alonso-Vale MI, Andreotti S, Peres SB, et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 2005; 288: E805-E812.
12. Kostoglou-Athanassiou I. Therapeutic applications of melatonin. Ther Adv Endocrinol Metab 2013; 4: 13-24.
13. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003; 50: 1129-1146.
14. Jaworek J, Konturek SJ, Leja-Szpak A, et al. Role of endogenous melatonin and its MT2 receptor in the modulation of caerulein-induced pancreatitis in the rat. J Physiol Pharmacol 2002; 53: 791-804.
15. Mantovani M, Kaster MP, Pertile R, Calixto JB, Rodrigues AL, Santos AR. Mechanisms involved in the antinociception caused by melatonin in mice. J Pineal Res 2006; 41: 382-389.
16. Vijayalaxmi B, Thomas CR, Reiter RJ, Herman T. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002; 20: 2575-2601.
17. Carrillo-Vico A, Garcia-Perganeda A, Naji L, Calvo JR, Romero MP, Guerrero JM. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell Mol Life Sci 2003; 60: 2272-2278.
18. Cini G, Neri B, Pacini A, et al. Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects. J Pineal Res 2005; 39: 12-20.
19. Tozawa T, Mishima K, Satoh K, Echizenya M, Shimizu T, Hishikawa Y. Stability of sleep timing against the melatonin secretion rhythm with advancing age: clinical implications. J Clin Endocrinol Metab 2003; 88: 4689-4695.
20. Zwirska-Korczala K, Jochem J, Adamczyk-Sowa M, et al. Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes-an in vitro study. J Physiol Pharmacol 2005; 56(Suppl. 6): 91-99.
21. Maldonado MD, Siu AW, Sanchez-Hidalgo M, Acuna-Castroviejo D, Escames G. Melatonin and lipid uptake by murine fibroblasts: clinical implications. Neuro Endocrinol Lett 2006; 27: 601-608.
22. Gonzalez A, Alvarez-Garcia V, Martinez-Campa C, Alonso-Gonzalez C, Cos S. Melatonin promotes differentiation of 3T3-L1 fibroblasts. J Pineal Res 2012; 52: 12-20.
23. Bogacka I, Bogacki M, Gaglewska M, Kurzynska A, Wasielak M. In vitro effect of peroxisome proliferator activated receptor (PPAR) ligands on prostaglandin E2 synthesis and secretion by porcine endometrium during the estrous cycle and early pregnancy. J Physiol Pharmacol 2013; 64: 47-54.
24. Alonso-Vale MI, Peres SB, Vernochet C, Farmer SR, Lima FB. Adipocyte differentiation is inhibited by melatonin through the regulation of C/EBPbeta transcriptional activity. J Pineal Res 2009; 47: 221-227.
25. Nakade O, Koyama H, Ariji H, Yajima A, Kaku T. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 1999; 27: 106-110.
26. Hipler UC, Fischer TW, Elsner P. HaCaT cell proliferation influenced by melatonin. Skin Pharmacol Appl Skin Physiol 2003: 16: 379-385.
27. Carossino AM, Lombardi A, Matucci-Cerinic M, Pignone A, Cagnoni M. Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. Clin Exp Rheumatol 1996; 14: 493-498.
28. Drazen DL, Bilu D, Bilbo SD, Nelson RJ. Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1476-R1482.
29. Kim MJ, Kim HK, Kim BS, Yim SV. Melatonin increases cell proliferation in the dentate gyrus of maternally separated rats. J Pineal Res 2004; 37: 193-197.
30. Zhang L, Su P, Xu C, et al. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARc expression and enhancing Runx2 expression. J Pineal Res 2010; 49: 364-372.
31. Moriya Y, Horie N, Mitome M, Shinohara K. Melatonin influences the proliferative and differentiative activity of neural stem cells. J Pineal Res 2007; 42: 411-418.
32. Casado-Zapico S, Rodriguez-Blanco J, Garcia-Santos G, et al. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway. J Pineal Res 2010; 48: 72-80.
33. Park SY, Jang WJ, Yi EY, et al. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1a stabilization under hypoxia. J Pineal Res 2010; 48: 178-184.
34. Cabrera J, Negrin G, Estevez F, Loro J, Reiter RJ, Quintana J. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J Pineal Res 2010; 49: 45-54.
35. Dubocovich ML, Cardinali DP, Delagrange P, et al. Melatonin receptors. In: The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media. London, 2000, pp. 270-277.
36. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006; 60: 97-108.
37. Mailliet F, Ferry G, Vella F, et al. Characterization of the melatoninergic MT3 binding site on the NRH: quinone oxidoreductase 2 enzyme. Biochem Pharmacol 2005; 71: 74-88.
38. Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 2003; 8: d1093-d1108.
39. Alonso-Vale MI, Andreotti S, Peres SB, et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 2005; 288: E805-E812.
40. Zalatan F, Krause JA, Blask DE. Inhibition of isoproterenolinduced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism. Endocrinology 2001; 142: 3783-3790.
41. Le Gouic S, Atgie C, Viguerie-Bascands N, et al. Characterization of a melatonin binding site in Siberian hamster brown adipose tissue. Eur J Pharmacol 1997; 339: 271-278.
42. Soto-Vega E, Meza I, Ramirez-Rodriguez G, Benitez-King G. Melatonin stimulates calmodulin phosphorylation by protein kinase C. J Pineal Res 2004; 37: 98-106.
43. Carrillo-Vico A, Lardone PJ, Fernandez-Santos JM et al. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2 receptor system. J Clin Endocrinol Metab 2005; 90: 992-1000.
44. Dubocovich ML. Luzindole (N-0774): a novel melatonin receptor antagonist. J Pharmacol Exp Ther 1988; 246: 902-910.
45. Kobayashi Y, Itoh MT, Kondo H, et al. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer. J Pineal Res 2003; 35: 71-76.
46. Rivera-Bermudez MA, Masana MI, Brown GM, Earnest DJ, Dubocovich MI. Immortalized cells from the rat suprachiasmatic nucleus express functional melatonin receptors. Brain Res 2004; 1002: 21-27.
47. Souza AV, Visconti MA, Castrucci AM. Melatonin biological activity and binding sites in human melanoma cells. J Pineal Res 2003; 34: 242-248.
48. Adamczyk-Sowa M, Sowa P, Zwirska-Korczala K, Pierzchala K, Bartosz G, Sadowska-Bartosz I. Role of melatonin receptor MT(2) and quinone reductase II in the regulation of the redox status of 3T3-L1 preadipocytes in vitro. Cell Biol Int 2013; 37: 835-842.
49. Alexander SP, Mathie A, Peters JA. 7TM Receptors. Br J Pharmacol 2007; 150(Suppl. 1): S4-S81.
50. Commins SP, Watson PM, Levin N, Beiler RJ, Gettys TW. Central leptin regulates the UCP1 and ob genes in brown and white adipose tissue via different beta-adrenoceptor subtypes. J Biol Chem 2000; 275: 33059-33067.
51. Lindquist JM, Fredriksson JM, Rehnmark S, Cannon B, Nedergaard J. Beta 3-and alpha1-adrenergic Erk1/2 activation is Src-but not Gi-mediated in brown adipocytes. J Biol Chem 2000; 275: 22670-22677.
52. Delagrange P, Atkinson J, Boutin A, et al. Therapeutic perspectives for melatonin agonists and antagonists. J Neuroendocrinol 2003; 15: 442-448.
53. Bartness TJ, Demas GE, Song CK. Seasonal changes in adiposity: the roles of the photoperiod, melatonin and other hormones, and sympathetic nervous system. Exp Biol Med (Maywood) 2002; 227: 363-376.
54. Mustonen AM, Nieminen P, Hyvarinen H. Melatonin and the wintering strategy of the tundra vole, Microtus oeconomus. Zoolog Sci 2002; 19: 683-687.
55. Prunet-Marcassus B, Desbazeille M, Bros A, et al. Melatonin reduces body weight gain in Sprague Dawley rats with dietinduced obesity. Endocrinology 2003; 144: 5347-5352.
56. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest 1998; 101: 1353-1361.
57. Murrel GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990; 265: 659-665.
58. Carriere A, Fernandez Y, Rigoulet M, Penicaud L, Casteilla L. Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species. FEBS Lett 2003; 550: 163-167.
59. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18: 775-794.
60. Havens CG, Ho A, Yoshioka N, Dowdy SF. Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species. Mol Cell Biol 2006; 26: 4701-4711.
61. Sainz RM, Mayo JC, Kotler M, Uria H, Antolin I, Rodriguez C. Melatonin decreases mRNA for histone H4 in thymus of young rats. Life Sci 1998; 63: 1109-1117.
62. Zhang JW, Klemm DJ, Vinson C, Lane MD. Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis. J Biol Chem 2004; 279: 4471-4478.
63. Nosjean O, Ferro M, Coge F, et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000; 275: 31311-31317.
64. Podda MV, Deriu F, Giaconi E, Milia M, Tolu E. Melatonin inhibits rat medial vestibular nucleus neuron activity in vitro. Neurosci Lett 2003; 341: 209-212.
65. Santagostino-Barbone MG, Masoero E, Spelta V, Lucchelli A. 2-Phenylmelatonin: a partial agonist at enteric melatonin receptors. Pharmacol Toxicol 2000; 87: 156-160.
66. Ha E, Yim SV, Chung JH, et al. Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells. J Pineal Res 2006; 41: 67-72.
67. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 2001; 58: 747-752.
68. Arendt J. The pineal gland: basic physiology and clinical implications. In: Endocrinology, LJ De Groot, JL Jameson (eds). Philadelphia, Elsevier Saunders, 2006, pp. 557-575.
69. Qin LQ, Li J, Wang Y, Wang J, Xu JY, Kaneko T. The effects of nocturnal life on endocrine circadian patterns in healthy adults. Life Sci 2003; 73: 2467-2475.
70. Wolden-Hanson T, Mitton DR, McCants RL, et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141: 487-497.
71. Hu Y, Rosen DG, Zhou Y, et al. Mitochondrial manganesesuperoxide dismutase expression in ovarian cancer. role in cell proliferation and response to oxidative stress. J Biol Chem 2005; 280: 39485-39492.
72. Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D. The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J Physiol Pharmacol 2013; 64: 409-421.
73. Sowa P, Adamczyk-Sowa M, Zwirska-Korczala K, Namyslowski G, Misiolek M, Pierzchala K. The role of serotonergic 5-HT1A receptors in central cardiovascular regulation in haemorrhagic shock in rats. J Physiol Pharmacol 2013; 64: 219-229.